Yesterday, European stocks returned to the downside. The Stoxx Europe 600 Index dropped 0.73%, Germany's DAX 30 lost 0.54%, France's CAC 40 sank 0.98%, and the U.K.'s FTSE 100 shed 1.27%.
72% of STOXX 600 constituents traded lower or unchanged yesterday.
45% of the shares trade above their 20D MA vs 54% Wednesday (below the 20D moving average).
47% of the shares trade above their 200D MA vs 50% Wednesday (above the 20D moving average).
The Euro Stoxx 50 Volatility index added 1pt to 24.94, a new 52w high.
SECTORS vs STOXX 600
3mths relative high: Financial Services, Industrial
3mths relative low: Telecom.
Europe Best 3 sectors
media, travel & leisure, industrial goods & services
Europe worst 3 sectors
basic resources, energy, telecommunications
The 10yr Bund yield rose 5bps to -0.51% (below its 20D MA). The 2yr-10yr yield spread rose 2bps to -17bps (above its 20D MA).
GE 07:00: Jun Industrial Production MoM, exp.: 7.8%
GE 07:00: Jun Current Account, exp.: E6.5B
GE 07:00: Jun Balance of Trade s.a, exp.: E7.6B
GE 07:00: Jun Exports MoM s.a, exp.: 9%
GE 07:00: Jun Imports MoM s.a, exp.: 3.5%
GE 07:00: Jun Balance of Trade, exp.: E7.1B
FR 07:45: Jun Current Account, exp.: E-8.5B
FR 07:45: Jun Balance of Trade, exp.: E-7.1B
FR 07:45: Jun Industrial Production MoM, exp.: 19.6%
FR 07:45: Q2 Private Non Farm Payrolls QoQ Prel, exp.: -2.5%
UK 08:30: Jul Halifax House Price Idx MoM, exp.: -0.1%
UK 08:30: Jul Halifax House Price Idx YoY, exp.: 2.5%
In Asian trading hours, the U.S. dollar strengthen up. EUR/USD turned down sinking back to 1.1824, and GBP/USD slid to test the support at 1.3085. USD/JPY showed upward momentum rising back to 105.60. USD/CAD shot up to 1.3365. AUD/USD sank back to 0.7205. China recorded a trade surplus of 62.33 billion dollars in July (vs a surplus of 42.6 billion dollars expected) with exports growing 7.2% on year (vs -0.6% expected).
Spot gold consolidated some gains, retreating to $2,051 an ounce.
#UK - IRELAND#
Standard Life Aberdeen, an investment company, posted 1H results: "Fee based revenue of 706 million pounds (H1 2019: 815 million pounds), 13% lower mainly reflecting 2019 outflows, client preferences changing asset mix in this environment, and Lloyds Banking Group (LBG) tranche withdrawals (...) IFRS loss before tax of 498 million pounds (H1 2019: 629 million pounds profit) reflecting impairment charges relating to goodwill and intangible assets partly offset by gains on sales of Indian investments (...) AUMA (Assets under management and administration) of 511.8 billion pounds after LBG tranche withdrawals (FY 2019: 544.6 billion pounds) (...) Maintained interim dividend at 7.3 pence (H1 2019: 7.3 pence)."
From a daily point of view, the share is trying to escape above the upper end of a symmetrical triangle drawn since June. Moreover, the Relative Strength Index (RSI, 14) has broken above a declining trendline, given us an advanced signal. Above 241.3p look for the previous resistance of March at 288.3p and 308.1p in extension.
Source: GAIN Capital, TradingView
Hikma Pharmaceuticals, a U.K.-based pharmaceutical firm, reported 1H results: "Group core revenue grew 9% to 1,132 million dollars (2019: 1,043 million dollars). (...) operating profit of 297 million dollars (H1 2019: 238 million dollars). (...) Profit attributable to shareholders was 212 million dollars (H1 2019: 185 million dollars). (...) Core basic earnings per share increased by 17% to 85.3 cents (H1 2019: 72.7 cents) (...) The Board is recommending an interim dividend of 16 cents per share (approximately 12 pence per share) (H1 2019: 14 cents per share)."
Hargreaves Lansdown, an investment management services provider, published full-year results: "2020 profit before tax grew by 24% to 378.3 million pounds. (...) The increase was driven by continued NNB-driven revenue growth and strong share dealing volumes in the second half of the year. (...) Total AUA (Assets Under Administration) increased by 5% to 104.0 billion pounds as at 30 June 2020 (99.3 billion pounds as at 30 June 2019). This was driven by 7.7 billion pounds of NNB (Net new business) offset by negative market movement of 3.0 billion pounds. (...) Total dividend up 31% at 54.9 pence per share."
Maurel & Prom, an oil & gas firm, said it swung to a 1H net loss of 606 million dollars from a net income of 33 million dollars in the prior-year period, citing an impairment charge of 474 million dollars. 1H sales were down 38% on year to 142 million dollars.
Danone, a dairy maker, was downgraded to "hold" from "buy" at Deutsche Bank.
Banca Monte Dei Paschi di Siena, an Italian bank, said it swung to a 2Q net loss of 845 million euros from a net income of 65 million euros in the prior-year period, citing 384 millions in provisions for legal claims and 476 million euros in a writedown of deferred tax assets.
Roche, a Swiss pharmaceutical major, announced that the Phase 3 trial on Tecentriq (atezolizumab) in combination with paclitaxel (chemotherapy) did not meet statistical significance on its primary endpoint of progression-free survival (PFS) for the initial (first-line) treatment of people with metastatic triple-negative breast cancer (TNBC).
Ahold Delhaize: E0.5
Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.
Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to Forex.com or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.